Papers/PMID:28273891
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.
Scientific reports2017The record
4 findings · 1 compound · 4 endpoints · 4 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
4 findings
magnesium(2+) — no detected effect on total cholesterol (TC)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×4“Fasting total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerol, non-esterified fatty acid (NEFA), glucose, insulin and HOMAIR did not differ after oral magnesium supplementation compared with the placebo treatment.”
Quoted verbatim from Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.. - Study
- RCT
- Duration
- 6 months
- Dose
- 350 mg magnesium per day as Magnesium Citrate Complex, three times daily
- Population
- Overweight and obese men and postmenopausal women, mean age 62 years, BMI 25-35 kg/m2, 24-week trial
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.2017PMID:28273891Industry fundedPermalink
magnesium(2+) — no detected effect on LDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×3“Fasting total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerol, non-esterified fatty acid (NEFA), glucose, insulin and HOMAIR did not differ after oral magnesium supplementation compared with the placebo treatment.”
Quoted verbatim from Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.. - Study
- RCT
- Duration
- 6 months
- Dose
- 350 mg magnesium per day as Magnesium Citrate Complex, three times daily
- Population
- Overweight and obese men and postmenopausal women, mean age 62 years, BMI 25-35 kg/m2, 24-week trial
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.2017PMID:28273891Industry fundedPermalink
magnesium(2+) — no detected effect on fasting blood glucose
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“Fasting total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerol, non-esterified fatty acid (NEFA), glucose, insulin and HOMAIR did not differ after oral magnesium supplementation compared with the placebo treatment.”
Quoted verbatim from Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.. - Study
- RCT
- Duration
- 6 months
- Dose
- 350 mg magnesium per day as Magnesium Citrate Complex, three times daily
- Population
- Overweight and obese men and postmenopausal women, mean age 62 years, BMI 25-35 kg/m2, 24-week trial
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.2017PMID:28273891Industry fundedPermalink
magnesium(2+) — no detected effect on HDL cholesterol
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×2“Fasting total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerol, non-esterified fatty acid (NEFA), glucose, insulin and HOMAIR did not differ after oral magnesium supplementation compared with the placebo treatment.”
Quoted verbatim from Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.. - Study
- RCT
- Duration
- 6 months
- Dose
- 350 mg magnesium per day as Magnesium Citrate Complex, three times daily
- Population
- Overweight and obese men and postmenopausal women, mean age 62 years, BMI 25-35 kg/m2, 24-week trial
Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults.2017PMID:28273891Industry fundedPermalink